GSK Halts Enrollment In Maternal RSV Vaccine Trials As Setback Intensifies

The company has not revealed any details of the potential safety issue that led to the decision.

pregnant woman
GSK's maternal vaccine for RSV faces a setback • Source: Alamy

More from R&D

More from Scrip